Eli Lilly Raises The Bar: Next-Gen Obesity Drug Delivers Massive 28% Weight Loss

In the rapidly expanding obesity treatment market, where Lilly competes with Novo Nordisk, the results were consistent with Wall Street estimates and could make retatrutide the most effective weight-loss medication.